Disease-Modifying Therapies in Lupus Nephritis: A Narrative Review Evaluating Currently Used Pharmacologic Agents

Askanase, A. D., Furie, R., Dall’Era, M., Bomback, A. S., Schwarting, A., Zhao, M.-H., Bruce, I. N., Khamashta, M., Rubin, B., Carroll, A., Levy, R. A., van Vollenhoven, R., & Urowitz, M. B. (2025). Disease-Modifying Therapies in Lupus Nephritis: A Narrative Review Evaluating Currently Used Pharmacologic Agents. Rheumatology and Therapy. https://doi.org/10.1007/s40744-025-00752-y
Authors:
Anca D Askanase
Richard Furie
Maria Dall'Era
Andrew S Bomback
Andreas Schwarting
Ming-Hui Zhao
Ian N Bruce
Munther Khamashta
Bernard Rubin
Angela Carroll
Roger Abramino Levy
Ronald van Vollenhoven
Murray B Urowitz
Affiliated Authors:
Anca D Askanase
Andrew S Bomback
Columbia Affiliation:
Author Keywords:
biological products
glucocorticoids
lupus erythematosus
lupus nephritis
systemic
elink
Publication Type:
Article
Unique ID:
10.1007/s40744-025-00752-y
PMID:
40186747
DOI:
10.1007/s40744-025-00752-y
Journal:
Rheumatology and Therapy
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: